178 related articles for article (PubMed ID: 12927933)
1. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids.
Chojkier M
J Hepatol; 2003 Sep; 39(3):437-46. PubMed ID: 12927933
[No Abstract] [Full Text] [Related]
2. [Hepatotoxicity of medicinal plants and plant-based preparations].
Pauwels A; Mostefa-Kara N
Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H79-85. PubMed ID: 8243922
[No Abstract] [Full Text] [Related]
3. Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.
Gao H; Ruan JQ; Chen J; Li N; Ke CQ; Ye Y; Lin G; Wang JY
Drug Des Devel Ther; 2015; 9():4861-8. PubMed ID: 26346783
[TBL] [Abstract][Full Text] [Related]
4. First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Yang M; Ruan J; Gao H; Li N; Ma J; Xue J; Ye Y; Fu PP; Wang J; Lin G
Arch Toxicol; 2017 Dec; 91(12):3913-3925. PubMed ID: 28620673
[TBL] [Abstract][Full Text] [Related]
5. Studies on medicinal plants of Sri Lanka: occurrence of pyrrolizidine alkaloids and hepatotoxic properties in some traditional medicinal herbs.
Arseculeratne SN; Gunatilaka AA; Panabokke RG
J Ethnopharmacol; 1981 Sep; 4(2):159-77. PubMed ID: 7311596
[TBL] [Abstract][Full Text] [Related]
6. Honey from plants containing pyrrolizidine alkaloids: a potential threat to health.
Edgar JA; Roeder E; Molyneux RJ
J Agric Food Chem; 2002 May; 50(10):2719-30. PubMed ID: 11982390
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.
Xiong A; Shao Y; Fang L; Yang X; Zhang S; Zheng J; Ding W; Yang L; Wang Z
Phytomedicine; 2019 Feb; 54():77-88. PubMed ID: 30668385
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
Yang M; Ruan J; Fu PP; Lin G
Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
[TBL] [Abstract][Full Text] [Related]
9. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Zhuge Y; Liu Y; Xie W; Zou X; Xu J; Wang J;
J Gastroenterol Hepatol; 2019 Apr; 34(4):634-642. PubMed ID: 30669184
[TBL] [Abstract][Full Text] [Related]
10. Tusanqi and hepatic sinusoidal obstruction syndrome.
Wang JY; Gao H
J Dig Dis; 2014 Mar; 15(3):105-7. PubMed ID: 24528632
[TBL] [Abstract][Full Text] [Related]
11. Toxic pyrrolizidine alkaloids provide a warning sign to overuse of the ethnomedicine Arnebia benthamii.
Ahmad L; He Y; Hao JC; Semotiuk A; Liu QR; Mazari P
J Ethnopharmacol; 2018 Jan; 210():88-94. PubMed ID: 28807851
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological analysis of 16 cases of pyrrolizidine alkaloids-associated hepatic sinusoidal obstruction syndrome].
Li YS; Bao J; Xu Y; Wang TL
Zhonghua Gan Zang Bing Za Zhi; 2020 Apr; 28(4):332-337. PubMed ID: 32403886
[No Abstract] [Full Text] [Related]
13. Magnetic Resonance Imaging Findings in Patients With Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome.
Li X; Yang X; Xu D; Li Q; Kong X; Lu Z; Bai T; Xu K; Ye J; Song Y
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):955-957. PubMed ID: 28126425
[No Abstract] [Full Text] [Related]
14. Budd-Chiari syndrome secondary to toxic pyrrolizidine alkaloid exposure.
Wu JS; Poon WT; Ma CK; Chen ML; Pang KS; Mak TW; Chan HB
Hong Kong Med J; 2013 Dec; 19(6):553-5. PubMed ID: 24310665
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease of the liver.
Srivastava RN; Mohabbat O
Am Heart J; 1977 Nov; 94(5):665. PubMed ID: 910703
[No Abstract] [Full Text] [Related]
16. Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids.
Luo S; Chu J; Huang H; Yao K
Biomed Res Int; 2018; 2018():9804582. PubMed ID: 30009181
[TBL] [Abstract][Full Text] [Related]
17. [Liver involvement in the course of phytotherapy].
Larrey D
Presse Med; 1994 Apr; 23(15):691-3. PubMed ID: 8072973
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.
Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y
BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495
[TBL] [Abstract][Full Text] [Related]
19. Sinusoidal obstruction syndrome.
Valla DC; Cazals-Hatem D
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):378-85. PubMed ID: 27038846
[TBL] [Abstract][Full Text] [Related]
20. Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group Study.
Cook BA; Sinnhuber JR; Thomas PJ; Olson TA; Silverman TA; Jones R; Whitehead VM; Ruymann FB
Cancer; 1983 Jul; 52(1):61-3. PubMed ID: 6573942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
